Cvs Health (CVS) Revenue (2009 - 2026)

Cvs Health (CVS) has reported Revenue for 18 consecutive years, with $106.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 7.26% year-over-year to $106.1 billion; the trailing twelve-month figure through Jun 2026 stood at $415.1 billion (up 7.36% YoY), and the FY2025 full-year result was $402.1 billion, up 7.85% from the prior year.
• Revenue climbed to $106.1 billion in Q2 2026 per CVS's latest filing, from $100.4 billion in the prior quarter.
• Across five years, Revenue topped out at $106.1 billion in Q2 2026 and bottomed at $76.8 billion in Q1 2022.
• Historically, Revenue has averaged $92.3 billion across 5 years, with a median of $92.5 billion in 2023.
• The sharpest annual moves came in 2023 and 2024: Revenue gained 11.89% in 2023, then advanced 2.6% in 2024.
• Over 5 years, Revenue stood at $83.8 billion in 2022, then increased by 11.89% to $93.8 billion in 2023, then advanced by 4.15% to $97.7 billion in 2024, then gained by 8.17% to $105.7 billion in 2025, then increased by 0.38% to $106.1 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $106.1 billion, $100.4 billion, and $105.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.